[EN] NOVEL DIHYDROPYRIMIDIN-2(1H)-ONE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS [FR] NOUVEAUX COMPOSÉS DIHYDROPYRIMIDINE-2(1H)-ONES EN TANT QU'INHIBITEURS DE LA S-NITROSOGLUTATHION RÉDUCTASE
IRIDIUM COMPLEX COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE OBTAINED BY USING THE SAME, AND USES OF THE DEVICE
申请人:Igarashi Takeshi
公开号:US20090315454A1
公开(公告)日:2009-12-24
The present invention provides an organic EL device having a high luminous efficiency and a long life, and an iridium complex compound used for preparing the above device.
The iridium complex compound is represented by the following Formula (1):
[in Formula (1), R
1
to R
4
are each independently a specific group; at least one of R
1
to R
4
is a group having 2 or more carbon atoms; R
5
to R
8
are each independently a specific group; and at least one of R
5
to R
8
is a specific electron-withdrawing group; (with the proviso that R
1
to R
8
are not combined with each other to form rings)].
Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
申请人:Sun Xicheng
公开号:US20120208817A1
公开(公告)日:2012-08-16
The present invention is directed to novel dihydropyrimidin-2(1H)-one compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.